KLK3 and neoplasm: Treatment of nude mice, injected with androgen-sensitive LNCaP prostate cancer cells, with BA caused a reduction in tumour growth of 25–38%, along with a reduction in plasma PSA levels of 88% (Gallardo-Williams et al, 2004).